Cost of RSV Hospitalization Could Decrease if Treatment Targets Children Younger Than 3 Months
June 5th 2023The sharp reduction in costs for hospitalization from respiratory syncytial virus (RSV) in infants 3 months and younger after the COVID-19 pandemic outweighed the cost increase for children aged 3 to 24 months.
Read More
What We’re Reading: Expanding Student Health Care; Depression Soars; RSV Vaccine for Infants
May 18th 2023The Biden administration said it will expand health care access, including mental health care, to students; depression reaches an all-time high in the United States; the FDA’s independent vaccine advisers are meeting to discuss the safety and effectiveness of a respiratory syncytial virus (RSV) vaccine.
Read More
Higher Rates of Respiratory Support Needed in Patients Admitted With RSV
April 10th 2023Patients who were admitted to the hospital for respiratory syncytial virus (RSV) had a higher risk of a complex hospital course and had higher rates of respiratory support compared with patients admitted for influenza.
Read More
Study Explores Mortality Rates and Risk Factors in Patients Hospitalized for RSV
April 5th 2023A recent study found the mortality rate for patients hospitalized for respiratory syncytial virus (RSV) to be 6.6%, with approximately 25% of hospitalized patients requiring admission to the intensive care unit.
Read More